MAP2K7 and hepatocellular carcinoma: In this research, the relationship between expression levels of phosphorylated ERK, a well known key downstream factor in the RAF/MEK/ERK signaling pathway, and Sorafenib response was examined using cell lines and patient‐derived primary HCC xenografts in a mouse model.